These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 21216209

  • 1. [Fatty liver and its clinical management in obese adolescents].
    González Jiménez E, Schmidt Río-Valle J, Álvarez Ferre J.
    Endocrinol Nutr; 2011 Jan; 58(1):32-7. PubMed ID: 21216209
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 3. [Non-alcoholic fatty liver disease].
    Calderaro J, Zafrani ES.
    Ann Pathol; 2010 Dec; 30(6):413-20. PubMed ID: 21167426
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Non-alcoholic fatty liver].
    Tagle Arrospide M.
    Rev Gastroenterol Peru; 2003 Dec; 23(1):49-57. PubMed ID: 12768215
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease in pediatric patients.
    Sinatra FR.
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):43S-8S. PubMed ID: 22237875
    [Abstract] [Full Text] [Related]

  • 11. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
    Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Jul; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 13. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 14. [An update on non-alcoholic fatty liver disease].
    Méndez-Sánchez N, Chávez-Tapia NC, Uribe M.
    Rev Invest Clin; 2004 Dec; 56(1):72-82. PubMed ID: 15144045
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [Abstract] [Full Text] [Related]

  • 17. [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].
    Crespo J, Cayón A, Pons-Romero F.
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():15-23. PubMed ID: 15195530
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatitis C and steatosis.
    Björnsson E, Angulo P.
    Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.